Clinical Trial Results

Central Vein Sign in Multiple Sclerosis Extension Study

NAINTERVENTIONAL Los Angeles, California +2 more

RECRUITING

MS-ResearchBiomarkerS

N/AOBSERVATIONAL Los Angeles, California

RECRUITING

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Pheonix, Arizona +4 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

PHASE1INTERVENTIONAL Newport Beach, California +4 more

RECRUITING

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NAINTERVENTIONAL Irvine, California +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Entire-body PET Scans for Multiple Sclerosis

EARLY_PHASE1INTERVENTIONAL Ladera Ranch, California

RECRUITING